Ticker Scorecard - ETNB Basics Company: 89bio, Inc. Common Stock IPO Date: November 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $933.6M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 3.40% Avg Daily Range (30 D): $0.22 | 3.02% Avg Daily Range (90 D): $0.24 | 3.00% Institutional Daily Volume Avg Daily Volume: .69M Avg Daily Volume (30 D): 1.08M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 98 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 948 Avg Inst. Trade: $2.08M Avg Inst. Trade (30 D): $1.23M Avg Inst. Trade (90 D): $1.18M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.47M Avg Closing Trade (30 D): $1.15M Avg Closing Trade (90 D): $1.04M Avg Closing Volume: 206.83K     News Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Nov 29, 2024 @ 6:30 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: N/A Nov 13, 2024 @ 4:58 AM 89bio, Inc. Announces Upsized Pricing of $125.0 Mi... Source: 89Bio, Inc. Jun 14, 2024 @ 8:05 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: 89bio, Inc. May 22, 2024 @ 8:05 PM 89bio to Present 48-Week Data from ENLIVEN Phase 2... Source: 89bio, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.39 $-.48 $-.54 Diluted EPS $-1.39 $-.48 $-.54 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -149.07M $ -47.97M $ -51.68M Operating Income / Loss $ -151.94M $ -53.44M $ -57.28M Cost of Revenue $ $ $ Net Cash Flow $ -120.81M $ -5.36M $ -98.59M PE Ratio